Live Breaking News & Updates on Abbvie Imbruvica

Stay updated with breaking news from Abbvie imbruvica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Heated Market For Dueling Blood Cancer Drugs Lands BeiGene In Court - BeiGene (NASDAQ:BGNE), AbbVie (NYSE:ABBV)

Key Takeaways: A unit of AbbVie has sued BeiGene for alleged patent infringement involving one of the Chinese company’s core products, Brukinsa The lawsuit comes amid rapidly growing sales for Brukinsa, which is used to treat blood cancer, even as sales for AbbVie’s competing product sag By Warren Yang ....

Hong Kong , New York , United States , Abbvie Imbruvica , Warren Yang , Drug Administration , Abbvie Inc , Beigene Ltd , Key Takeaways , Fierce Pharma , New York Listed ,

Janssen and AbbVie's Imbruvica combination recommended by NICE for leukaemia

Janssen and AbbVie's Imbruvica combination recommended by NICE for leukaemia
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Abbvie Imbruvica , Amanda Cunnington , Abbvie Venclyxta , Hilary Lindsay , Janssen Pharmaceutical Companies Of Johnson , National Institute For Health , Regulatory Agency , Janssen Pharmaceutical Companies , National Institute , Care Excellence , Janssen Cilag Limited ,